Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH
On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.
Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment
A recent study revealed disparities in gynecologic oncology clinical trial enrollment, impacting the outcomes of underrepresented racial and ethnic groups.
Higher abnormal cervical cancer screening rates reported among veterans
A recent study found that military veterans have 1.46 times higher odds of abnormal outcomes from cervical cancer screening tests compared to non-veterans.
Contemporary OBGYN week in review: cervical cancer, cesarean birth, and more
2 Commerce Drive Cranbury, NJ 08512